Third Rock, J&J neuroscience spinout Rapport outlines IPO plans
The new year burst of biotech IPOs may have sputtered out months ago, but Rapport is a reminder that companies are still willing to test the waters
Source: fiercebiotech.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Abe Ceesay. Real-time updates on events, politics, business and more.